Tissue  ||| S:0 E:7 ||| NN
hemoglobin  ||| S:7 E:18 ||| NN
index ||| S:18 E:23 ||| NN
:  ||| S:23 E:25 ||| :
a  ||| S:25 E:27 ||| DT
non-invasive  ||| S:27 E:40 ||| JJ
optical  ||| S:40 E:48 ||| JJ
measure  ||| S:48 E:56 ||| NN
of  ||| S:56 E:59 ||| IN
total  ||| S:59 E:65 ||| JJ
tissue  ||| S:65 E:72 ||| NN
hemoglobin  ||| S:72 E:83 ||| VBD
The  ||| S:83 E:87 ||| DT
tissue  ||| S:87 E:94 ||| NN
hemoglobin  ||| S:94 E:105 ||| NN
index  ||| S:105 E:111 ||| NN
( ||| S:111 E:112 ||| -LRB-
THI ||| S:112 E:115 ||| NNP
)  ||| S:115 E:117 ||| -RRB-
is  ||| S:117 E:120 ||| VBZ
a  ||| S:120 E:122 ||| DT
hemoglobin  ||| S:122 E:133 ||| NN
signal  ||| S:133 E:140 ||| NN
strength  ||| S:140 E:149 ||| NN
metric  ||| S:149 E:156 ||| VBZ
provided  ||| S:156 E:165 ||| VBN
on  ||| S:165 E:168 ||| IN
the  ||| S:168 E:172 ||| DT
InSpectra  ||| S:172 E:182 ||| JJ
StO2  ||| S:182 E:187 ||| NNP
Tissue  ||| S:187 E:194 ||| NNP
Oxygenation  ||| S:194 E:206 ||| NNP
Monitor ||| S:206 E:213 ||| NNP
,  ||| S:213 E:215 ||| ,
Model  ||| S:215 E:221 ||| NNP
650 ||| S:221 E:224 ||| CD
.  ||| S:224 E:226 ||| .
There  ||| S:226 E:232 ||| EX
is  ||| S:232 E:235 ||| VBZ
growing  ||| S:235 E:243 ||| VBG
interest  ||| S:243 E:252 ||| NN
regarding  ||| S:252 E:262 ||| VBG
the  ||| S:262 E:266 ||| DT
physiologic  ||| S:266 E:278 ||| JJ
meaning  ||| S:278 E:286 ||| NN
of  ||| S:286 E:289 ||| IN
THI  ||| S:289 E:293 ||| NNP
and  ||| S:293 E:297 ||| CC
whether  ||| S:297 E:305 ||| IN
a  ||| S:305 E:307 ||| DT
clinically  ||| S:307 E:318 ||| JJ
useful  ||| S:318 E:325 ||| JJ
correlation  ||| S:325 E:337 ||| NN
between  ||| S:337 E:345 ||| IN
THI  ||| S:345 E:349 ||| NNP
and  ||| S:349 E:353 ||| CC
blood  ||| S:353 E:359 ||| NN
hemoglobin  ||| S:359 E:370 ||| NN
concentration  ||| S:370 E:384 ||| NN
exists ||| S:384 E:390 ||| VBZ
.  ||| S:390 E:392 ||| .
A  ||| S:392 E:394 ||| DT
series  ||| S:394 E:401 ||| NN
of  ||| S:401 E:404 ||| IN
in  ||| S:404 E:407 ||| IN
vitro  ||| S:407 E:413 ||| NN
and  ||| S:413 E:417 ||| CC
in  ||| S:417 E:420 ||| IN
vivo  ||| S:420 E:425 ||| JJ
experiments  ||| S:425 E:437 ||| NNS
was  ||| S:437 E:441 ||| VBD
performed  ||| S:441 E:451 ||| VBN
to  ||| S:451 E:454 ||| TO
evaluate  ||| S:454 E:463 ||| VB
whether  ||| S:463 E:471 ||| IN
THI  ||| S:471 E:475 ||| NNP
has  ||| S:475 E:479 ||| VBZ
potential  ||| S:479 E:489 ||| JJ
utility  ||| S:489 E:497 ||| NN
beyond  ||| S:497 E:504 ||| IN
its  ||| S:504 E:508 ||| PRP$
primary  ||| S:508 E:516 ||| JJ
purpose  ||| S:516 E:524 ||| NN
of  ||| S:524 E:527 ||| IN
helping  ||| S:527 E:535 ||| VBG
InSpectra  ||| S:535 E:545 ||| JJ
device  ||| S:545 E:552 ||| NN
users  ||| S:552 E:558 ||| NNS
optimally  ||| S:558 E:568 ||| JJ
position  ||| S:568 E:577 ||| NN
a  ||| S:577 E:579 ||| DT
StO2  ||| S:579 E:584 ||| JJ
sensor  ||| S:584 E:591 ||| NN
over  ||| S:591 E:596 ||| IN
muscle  ||| S:596 E:603 ||| NN
tissue ||| S:603 E:609 ||| NN
.  ||| S:609 E:611 ||| .
The  ||| S:611 E:615 ||| DT
THI  ||| S:615 E:619 ||| NNP
and  ||| S:619 E:623 ||| CC
tissue  ||| S:623 E:630 ||| NN
hemoglobin  ||| S:630 E:641 ||| NN
oxygen  ||| S:641 E:648 ||| NN
saturation  ||| S:648 E:659 ||| NNS
( ||| S:659 E:660 ||| -LRB-
StO2 ||| S:660 E:664 ||| NNP
)  ||| S:664 E:666 ||| -RRB-
were  ||| S:666 E:671 ||| VBD
measured  ||| S:671 E:680 ||| VBN
using  ||| S:680 E:686 ||| VBG
the  ||| S:686 E:690 ||| DT
InSpectra  ||| S:690 E:700 ||| JJ
StO2  ||| S:700 E:705 ||| NNP
Tissue  ||| S:705 E:712 ||| NNP
Oxygenation  ||| S:712 E:724 ||| NNP
Monitor ||| S:724 E:731 ||| NNP
,  ||| S:731 E:733 ||| ,
Model  ||| S:733 E:739 ||| NNP
650 ||| S:739 E:742 ||| CD
,  ||| S:742 E:744 ||| ,
with  ||| S:744 E:749 ||| IN
a  ||| S:749 E:751 ||| DT
15  ||| S:751 E:754 ||| CD
mm  ||| S:754 E:757 ||| CD
optical  ||| S:757 E:765 ||| JJ
sensor ||| S:765 E:771 ||| NN
.  ||| S:771 E:773 ||| .
A  ||| S:773 E:775 ||| DT
THI  ||| S:775 E:779 ||| NNP
normal  ||| S:779 E:786 ||| JJ
reference  ||| S:786 E:796 ||| NN
range  ||| S:796 E:802 ||| NN
was  ||| S:802 E:806 ||| VBD
established  ||| S:806 E:818 ||| VBN
in  ||| S:818 E:821 ||| IN
the  ||| S:821 E:825 ||| DT
thenar  ||| S:825 E:832 ||| JJ
eminence  ||| S:832 E:841 ||| NNS
( ||| S:841 E:842 ||| -LRB-
hand ||| S:842 E:846 ||| NN
)  ||| S:846 E:848 ||| -RRB-
for  ||| S:848 E:852 ||| IN
434  ||| S:852 E:856 ||| CD
nonhospitalized  ||| S:856 E:872 ||| CD
human  ||| S:872 E:878 ||| JJ
volunteers ||| S:878 E:888 ||| NNS
.  ||| S:888 E:890 ||| .
In  ||| S:890 E:893 ||| IN
30  ||| S:893 E:896 ||| CD
subjects ||| S:896 E:904 ||| NNS
,  ||| S:904 E:906 ||| ,
the  ||| S:906 E:910 ||| DT
thenar  ||| S:910 E:917 ||| JJ
THI  ||| S:917 E:921 ||| NNP
was  ||| S:921 E:925 ||| VBD
also  ||| S:925 E:930 ||| RB
evaluated  ||| S:930 E:940 ||| VBN
during  ||| S:940 E:947 ||| IN
5-minute  ||| S:947 E:956 ||| CD
arterial  ||| S:956 E:965 ||| NNS
and  ||| S:965 E:969 ||| CC
venous  ||| S:969 E:976 ||| JJ
blood  ||| S:976 E:982 ||| NN
flow  ||| S:982 E:987 ||| NN
occlusions ||| S:987 E:997 ||| NN
,  ||| S:997 E:999 ||| ,
and  ||| S:999 E:1003 ||| CC
with  ||| S:1003 E:1008 ||| IN
blood  ||| S:1008 E:1014 ||| NN
volume  ||| S:1014 E:1021 ||| NN
exsanguination  ||| S:1021 E:1036 ||| NN
in  ||| S:1036 E:1039 ||| IN
the  ||| S:1039 E:1043 ||| DT
hand  ||| S:1043 E:1048 ||| NN
induced  ||| S:1048 E:1056 ||| NN
with  ||| S:1056 E:1061 ||| IN
an  ||| S:1061 E:1064 ||| DT
Esmarch  ||| S:1064 E:1072 ||| JJ
bandage ||| S:1072 E:1079 ||| NN
.  ||| S:1079 E:1081 ||| .
In  ||| S:1081 E:1084 ||| IN
addition ||| S:1084 E:1092 ||| NN
,  ||| S:1092 E:1094 ||| ,
correlation  ||| S:1094 E:1106 ||| NN
of  ||| S:1106 E:1109 ||| IN
the  ||| S:1109 E:1113 ||| DT
THI  ||| S:1113 E:1117 ||| NNP
to  ||| S:1117 E:1120 ||| TO
blood  ||| S:1120 E:1126 ||| VB
total  ||| S:1126 E:1132 ||| JJ
hemoglobin  ||| S:1132 E:1143 ||| NN
concentration  ||| S:1143 E:1157 ||| NN
( ||| S:1157 E:1158 ||| -LRB-
Hbt ||| S:1158 E:1161 ||| NNP
)  ||| S:1161 E:1163 ||| -RRB-
was  ||| S:1163 E:1167 ||| VBD
studied  ||| S:1167 E:1175 ||| VBN
in  ||| S:1175 E:1178 ||| IN
five  ||| S:1178 E:1183 ||| CD
pigs  ||| S:1183 E:1188 ||| NNS
whose  ||| S:1188 E:1194 ||| WP$
Hbt  ||| S:1194 E:1198 ||| NNP
was  ||| S:1198 E:1202 ||| VBD
isovolumetrically  ||| S:1202 E:1220 ||| VBN
diluted  ||| S:1220 E:1228 ||| VBN
from  ||| S:1228 E:1233 ||| IN
13  ||| S:1233 E:1236 ||| CD
to  ||| S:1236 E:1239 ||| TO
4  ||| S:1239 E:1241 ||| CD
g ||| S:1241 E:1242 ||| CD
/ ||| S:1242 E:1243 ||| CD
dl  ||| S:1243 E:1246 ||| CD
systemically  ||| S:1246 E:1259 ||| NNS
and  ||| S:1259 E:1263 ||| CC
0.5  ||| S:1263 E:1267 ||| CD
g ||| S:1267 E:1268 ||| CD
/ ||| S:1268 E:1269 ||| CD
dl  ||| S:1269 E:1272 ||| NNS
locally  ||| S:1272 E:1280 ||| RB
in  ||| S:1280 E:1283 ||| IN
the  ||| S:1283 E:1287 ||| DT
hind  ||| S:1287 E:1292 ||| JJ
limb ||| S:1292 E:1296 ||| NN
.  ||| S:1296 E:1298 ||| .
The  ||| S:1298 E:1302 ||| DT
sensitivity  ||| S:1302 E:1314 ||| NN
and  ||| S:1314 E:1318 ||| CC
specificity  ||| S:1318 E:1330 ||| NN
of  ||| S:1330 E:1333 ||| IN
the  ||| S:1333 E:1337 ||| DT
THI  ||| S:1337 E:1341 ||| NNP
to  ||| S:1341 E:1344 ||| TO
measure  ||| S:1344 E:1352 ||| VB
tissue  ||| S:1352 E:1359 ||| NN
hemoglobin  ||| S:1359 E:1370 ||| NN
concentration  ||| S:1370 E:1384 ||| NN
( ||| S:1384 E:1385 ||| -LRB-
THC ||| S:1385 E:1388 ||| NNP
)  ||| S:1388 E:1390 ||| -RRB-
were  ||| S:1390 E:1395 ||| VBD
characterized  ||| S:1395 E:1409 ||| VBN
in  ||| S:1409 E:1412 ||| IN
vitro  ||| S:1412 E:1418 ||| NNS
using  ||| S:1418 E:1424 ||| VBG
isolated  ||| S:1424 E:1433 ||| JJ
blood  ||| S:1433 E:1439 ||| NN
tissue  ||| S:1439 E:1446 ||| NN
phantoms ||| S:1446 E:1454 ||| NN
.  ||| S:1454 E:1456 ||| .
In  ||| S:1456 E:1459 ||| IN
human  ||| S:1459 E:1465 ||| JJ
thenar  ||| S:1465 E:1472 ||| JJ
tissue ||| S:1472 E:1478 ||| NN
,  ||| S:1478 E:1480 ||| ,
the  ||| S:1480 E:1484 ||| DT
average  ||| S:1484 E:1492 ||| JJ
THI  ||| S:1492 E:1496 ||| NNP
was  ||| S:1496 E:1500 ||| VBD
14.1  ||| S:1500 E:1505 ||| CD
+ ||| S:1505 E:1506 ||| CD
/ ||| S:1506 E:1507 ||| CD
-  ||| S:1507 E:1509 ||| :
1.6  ||| S:1509 E:1513 ||| CD
( ||| S:1513 E:1514 ||| -LRB-
mean  ||| S:1514 E:1519 ||| VB
+ ||| S:1519 E:1520 ||| CD
/ ||| S:1520 E:1521 ||| CD
-  ||| S:1521 E:1523 ||| :
standard  ||| S:1523 E:1532 ||| JJ
deviation ||| S:1532 E:1541 ||| NN
) ||| S:1541 E:1542 ||| -RRB-
.  ||| S:1542 E:1544 ||| .
The  ||| S:1544 E:1548 ||| DT
THI  ||| S:1548 E:1552 ||| NNP
extrapolated  ||| S:1552 E:1565 ||| VBD
to  ||| S:1565 E:1568 ||| TO
100 ||| S:1568 E:1571 ||| CD
%  ||| S:1571 E:1573 ||| NN
blood  ||| S:1573 E:1579 ||| NN
volume  ||| S:1579 E:1586 ||| NN
exsanguination  ||| S:1586 E:1601 ||| NNS
was  ||| S:1601 E:1605 ||| VBD
3.7  ||| S:1605 E:1609 ||| CD
+ ||| S:1609 E:1610 ||| CD
/ ||| S:1610 E:1611 ||| CD
-  ||| S:1611 E:1613 ||| :
2.0  ||| S:1613 E:1617 ||| CD
units  ||| S:1617 E:1623 ||| NNS
presumably  ||| S:1623 E:1634 ||| RB
from  ||| S:1634 E:1639 ||| IN
myoglobin ||| S:1639 E:1648 ||| NN
.  ||| S:1648 E:1650 ||| .
On  ||| S:1650 E:1653 ||| IN
average ||| S:1653 E:1660 ||| NN
,  ||| S:1660 E:1662 ||| ,
the  ||| S:1662 E:1666 ||| DT
THI  ||| S:1666 E:1670 ||| NNP
increased  ||| S:1670 E:1680 ||| VBD
1.5  ||| S:1680 E:1684 ||| CD
+ ||| S:1684 E:1685 ||| CD
/ ||| S:1685 E:1686 ||| CD
-  ||| S:1686 E:1688 ||| :
1.0  ||| S:1688 E:1692 ||| CD
units  ||| S:1692 E:1698 ||| NNS
with  ||| S:1698 E:1703 ||| IN
venous  ||| S:1703 E:1710 ||| JJ
occlusion  ||| S:1710 E:1720 ||| NN
and  ||| S:1720 E:1724 ||| CC
decreased  ||| S:1724 E:1734 ||| VBD
4.0  ||| S:1734 E:1738 ||| CD
+ ||| S:1738 E:1739 ||| CD
/ ||| S:1739 E:1740 ||| CD
-  ||| S:1740 E:1742 ||| :
2.0  ||| S:1742 E:1746 ||| CD
units  ||| S:1746 E:1752 ||| NNS
with  ||| S:1752 E:1757 ||| IN
arterial  ||| S:1757 E:1766 ||| JJ
occlusion ||| S:1766 E:1775 ||| NN
.  ||| S:1775 E:1777 ||| .
In  ||| S:1777 E:1780 ||| IN
porcine  ||| S:1780 E:1788 ||| JJ
hind  ||| S:1788 E:1793 ||| JJ
limbs ||| S:1793 E:1798 ||| NNS
,  ||| S:1798 E:1800 ||| ,
the  ||| S:1800 E:1804 ||| DT
THI  ||| S:1804 E:1808 ||| NNP
weakly  ||| S:1808 E:1815 ||| VBD
correlated  ||| S:1815 E:1826 ||| VBN
with  ||| S:1826 E:1831 ||| IN
Hbt  ||| S:1831 E:1835 ||| NNP
( ||| S:1835 E:1836 ||| -LRB-
r2  ||| S:1836 E:1839 ||| CD
=  ||| S:1839 E:1841 ||| SYM
0.26 ||| S:1841 E:1845 ||| CD
)  ||| S:1845 E:1847 ||| -RRB-
while  ||| S:1847 E:1853 ||| IN
DeltaTHI  ||| S:1853 E:1862 ||| JJ
during  ||| S:1862 E:1869 ||| IN
venous  ||| S:1869 E:1876 ||| JJ
occlusion  ||| S:1876 E:1886 ||| NN
had  ||| S:1886 E:1890 ||| VBD
a  ||| S:1890 E:1892 ||| DT
stronger  ||| S:1892 E:1901 ||| JJR
correlation  ||| S:1901 E:1913 ||| NN
( ||| S:1913 E:1914 ||| -LRB-
r2  ||| S:1914 E:1917 ||| CD
=  ||| S:1917 E:1919 ||| SYM
0.62 ||| S:1919 E:1923 ||| CD
) ||| S:1923 E:1924 ||| -RRB-
.  ||| S:1924 E:1926 ||| .
In  ||| S:1926 E:1929 ||| IN
vitro  ||| S:1929 E:1935 ||| JJ
tests  ||| S:1935 E:1941 ||| NNS
indicated  ||| S:1941 E:1951 ||| VBD
that  ||| S:1951 E:1956 ||| IN
THI  ||| S:1956 E:1960 ||| NNP
strongly  ||| S:1960 E:1969 ||| RB
correlated  ||| S:1969 E:1980 ||| JJ
( ||| S:1980 E:1981 ||| -LRB-
r2  ||| S:1981 E:1984 ||| CD
>  ||| S:1984 E:1986 ||| CD
0.99 ||| S:1986 E:1990 ||| CD
)  ||| S:1990 E:1992 ||| -RRB-
to  ||| S:1992 E:1995 ||| TO
phantom  ||| S:1995 E:2003 ||| VB
THC  ||| S:2003 E:2007 ||| NNP
and  ||| S:2007 E:2011 ||| CC
was  ||| S:2011 E:2015 ||| VBD
insensitive  ||| S:2015 E:2027 ||| VBN
to  ||| S:2027 E:2030 ||| TO
StO2  ||| S:2030 E:2035 ||| CD
changes ||| S:2035 E:2042 ||| NNS
.  ||| S:2042 E:2044 ||| .
Steady-state  ||| S:2044 E:2057 ||| NNP
THI  ||| S:2057 E:2061 ||| NNP
values  ||| S:2061 E:2068 ||| NNS
do  ||| S:2068 E:2071 ||| VBP
not  ||| S:2071 E:2075 ||| RB
reliably  ||| S:2075 E:2084 ||| RB
indicate  ||| S:2084 E:2093 ||| VB
Hbt ||| S:2093 E:2096 ||| NNP
.  ||| S:2096 E:2098 ||| .
The  ||| S:2098 E:2102 ||| DT
THI  ||| S:2102 E:2106 ||| NNP
is  ||| S:2106 E:2109 ||| VBZ
a  ||| S:2109 E:2111 ||| DT
reproducible  ||| S:2111 E:2124 ||| JJ
quantitative  ||| S:2124 E:2137 ||| JJ
index  ||| S:2137 E:2143 ||| NN
for  ||| S:2143 E:2147 ||| IN
THC ||| S:2147 E:2150 ||| NNP
,  ||| S:2150 E:2152 ||| ,
and  ||| S:2152 E:2156 ||| CC
THI  ||| S:2156 E:2160 ||| NNP
trends  ||| S:2160 E:2167 ||| NNS
can  ||| S:2167 E:2171 ||| MD
discriminate  ||| S:2171 E:2184 ||| VB
between  ||| S:2184 E:2192 ||| IN
arterial  ||| S:2192 E:2201 ||| NN
or  ||| S:2201 E:2204 ||| CC
venous  ||| S:2204 E:2211 ||| JJ
blood  ||| S:2211 E:2217 ||| NN
flow  ||| S:2217 E:2222 ||| NN
occlusions ||| S:2222 E:2232 ||| NN
.  ||| S:2232 E:2234 ||| .
The  ||| S:2234 E:2238 ||| DT
THI  ||| S:2238 E:2242 ||| NNP
magnitude  ||| S:2242 E:2252 ||| NN
permits  ||| S:2252 E:2260 ||| VBZ
the  ||| S:2260 E:2264 ||| DT
estimation  ||| S:2264 E:2275 ||| NN
of  ||| S:2275 E:2278 ||| IN
myoglobin ||| S:2278 E:2287 ||| NN
's  ||| S:2287 E:2290 ||| POS
contribution  ||| S:2290 E:2303 ||| NN
to  ||| S:2303 E:2306 ||| TO
StO2 ||| S:2306 E:2310 ||| CD
.  ||| S:2310 E:2312 ||| .
